Jiang Zhenyu相关文献与解析，生知库 | 链接生命科学的每一步

Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study

Xeligekimab（一种白细胞介素-17A拮抗剂）治疗中国活动性放射学轴性脊柱关节炎患者的16周和48周结果：一项III期随机、双盲、安慰剂对照研究

Zhang, Shangzhu; Xu, Dong; Liu, Shengyun; Li, Shujie; Wang, Xiaoxia; Yuan, Fenghong; Gou, Wei; Xu, Baijie; Sun, Lingyun; Gu, Jieruo; Zhou, Dongmei; Li, Xiaomei; Kong, Ning; Zhao, Yi; Hao, Jie; Li, Tianwang; Fan, Xiaoyun; Shu, Qiang; Wei, Hua; Jiang, Tao; Yang, Jing; Qian, Long; Sun, Hongsheng; Cai, Xiaoyan; Jiang, Zhenyu; Yuan, Guohua; Qin, Li; Yang, Min; Xu, Jian; Fan, Wenqiang; Sun, Li; Zhang, Hua; Zhang, Chunyan; Zhang, Ning; Da, Zhanyun; Hu, Jiankang; Jin, Jingchun; Liu, Ju; Dai, Lie; Dong, Lingli; Wang, Wei; Zeng, Xiaofeng

关节炎

细胞生物学

发表日期：2026

文献求助收藏

Efficacy and safety of Xeligekimab (GR1501) in the treatment of axial Spondyloarthritis: Results from a Phase II clinical trial

Xeligekimab (GR1501) 治疗中轴型脊柱关节炎的疗效和安全性：一项 II 期临床试验的结果

期刊:Rheumatology and Immunology Research

影响因子:2.5

doi:10.1515/rir-2026-0016

Zeng, Xiaofeng; Zhang, Shangzhu; Liu, Huaxiang; Zhao, Yi; Li, Xiaomei; Jiang, Zhenyu; Xue, Yu; Kong, Ning; Sun, Lingyun; Liu, Shengyun; Fan, Xiaoyun; Hu, Jiankang; Shen, Liying; Xu, Dong

关节炎

发表日期：2026

文献求助收藏

Interferon-stimulated gene screening identifies CCND3 as a host restriction factor against emerging high-pathogenic bandaviruses.

干扰素刺激基因筛选发现 CCND3 是宿主对抗新出现的高致病性班达病毒的限制因子

期刊:Nature Communications

影响因子:15.7

doi:10.1038/s41467-025-63295-4

Xu Zhao, Jiang Zhenyu, Feng Kuan, Zhang Haiyan, Shi Chen, Deng Fei, Wang Hualin, Ning Yun-Jia

其它

发表日期：2025

文献求助收藏

Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double-Blind, Phase 3 Trial in China

多替努拉与非布司他治疗痛风的疗效和安全性比较：一项在中国开展的随机、多中心、双盲3期临床试验

期刊:Arthritis & Rheumatology

影响因子:10.9

doi:10.1002/art.43261

Sun, Jia; Wang, Yu; Cheng, Yongjing; Guo, Dongmei; Hu, Jiankang; Liu, Dongzhou; Gao, Zhengnan; Li, Changgui; Lu, Yibing; Kong, Xiaodan; Liu, Yu; Jiang, Zhenyu; Yi, Bin; Zhang, Hongfeng; Xu, Baijie; Yu, Shihao; Kokan, Rieko; Ishikawa, Kohei; Kawakatsu, Mikiko; Zhang, Zhuoli

Timp2-modified gelatinhydroxyphenylpropionic acid hydrogels reverse enhanced scleral recovery and suppress myopia development in mice.

Timp2 修饰的明胶羟苯丙酸水凝胶可逆转小鼠的巩膜恢复增强并抑制近视发展

期刊:Materials Today Bio

影响因子:10.2

doi:10.1016/j.mtbio.2025.101942

Liu Kaiqi, Li Ting, Gu Lingwen, Jiang Zhenyu, Jiang Jing, Yang Xi, Zhou Yang, Feng Xiao, Gong Qianqian, Zhao Lihua, Chen Yiming, Yang Chao, Jiang Tao

其它

发表日期：2025

文献求助收藏

Tocilizumab Monotherapy or Combined With Methotrexate for Rheumatoid Arthritis: A Randomized Clinical Trial

托珠单抗单药治疗或联合甲氨蝶呤治疗类风湿性关节炎：一项随机临床试验

期刊:Jama Network Open

影响因子:9.7

doi:10.1001/jamanetworkopen.2025.11095

Liu, Tian; Wang, Li; Zhang, Xiao; Chen, Linjie; Liu, Yi; Jiang, Zhenyu; Shuai, Zongwen; Zhang, Miaojia; Wei, Wei; Liu, Huaxiang; Xu, Jian; Zhang, Zhiyi; Wang, Guochun; Wang, Xiaoxia; Hu, Jiankang; Li, Hongbin; Zhang, Zhuoli; Wang, Hongzhi; Lu, Fuai; Du, Yingjue; Xue, Zenghui; Zhao, Yan; Li, Zhanguo

关节炎

发表日期：2025

文献求助收藏

Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trial

Janus激酶1/2抑制剂KL130008治疗活动性类风湿性关节炎的疗效和安全性：一项随机、双盲、安慰剂对照的II期试验

期刊:BMC Medicine

影响因子:8.3

doi:10.1186/s12916-025-04566-1

Cheng, Yue; Tang, Honghu; Qing, Yufeng; Liu, Yuan; Yang, Lei; Dang, Wantai; Yu, Jing; Li, Rongbin; Liu, Huaxiang; Jiang, Zhenyu; Sun, Hongsheng; Yin, Songlou; Cheng, Jianzhao; Li, Zhijun; Fan, Wenqiang; Zhang, Hong; Du, Hongwei; Fu, Zili; Ma, Xinmei; Wu, Jian; Duan, Lihua; Zhang, Rong; Lin, Jinying; Da, Zhanyun; Wei, Wei; Zhai, Qianxun; Wu, Bingjie; Yi, Xiaowei; Jin, Xiaoping; Ge, Junyou; Feng, Ping; Liu, Yi

Systemic lupus erythematosus related thrombotic microangiopathy: A retrospective study based on Chinese SLE Treatment and Research Group (CSTAR) registry

系统性红斑狼疮相关血栓性微血管病：基于中国系统性红斑狼疮治疗与研究组（CSTAR）注册登记的回顾性研究

期刊:Chinese Medical Journal

影响因子:7.3

doi:10.1097/CM9.0000000000003388

Zhang, Yupei; Jiang, Nan; Chen, Zhen; Duan, Xinwang; Shi, Xiaofei; Li, Hongbin; Jiang, Zhenyu; Wang, Yuhua; Wang, Yanhong; Zhao, Jiuliang; Wang, Qian; Tian, Xinping; Li, Mengtao; Zeng, Xiaofeng

Damage Evolution and Lifetime Prediction of Cement Asphalt Mortar Under High-Speed Train Frequency and Temperature Gradient Load

高速列车频率和温度梯度荷载作用下水泥沥青砂浆的损伤演化及寿命预测

期刊:Materials

影响因子:3.2

doi:10.3390/ma18051011

Zhou, Mingjie; Zhong, Shenghua; Liu, Yiping; Liu, Zejia; Yang, Bao; Jiang, Zhenyu; Zhou, Licheng; Tang, Liqun

发表日期：2025

文献求助收藏

Glutamate nanoregulator for metabolic immunotherapy of biofilm-associated implant infections

用于生物膜相关植入物感染代谢免疫疗法的谷氨酸纳米调节剂

Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study

Xeligekimab（一种白细胞介素-17A拮抗剂）治疗中国活动性放射学轴性脊柱关节炎患者的16周和48周结果：一项III期随机、双盲、安慰剂对照研究

Efficacy and safety of Xeligekimab (GR1501) in the treatment of axial Spondyloarthritis: Results from a Phase II clinical trial

Xeligekimab (GR1501) 治疗中轴型脊柱关节炎的疗效和安全性：一项 II 期临床试验的结果

Interferon-stimulated gene screening identifies CCND3 as a host restriction factor against emerging high-pathogenic bandaviruses.

干扰素刺激基因筛选发现 CCND3 是宿主对抗新出现的高致病性班达病毒的限制因子

Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double-Blind, Phase 3 Trial in China

多替努拉与非布司他治疗痛风的疗效和安全性比较：一项在中国开展的随机、多中心、双盲3期临床试验

Timp2-modified gelatinhydroxyphenylpropionic acid hydrogels reverse enhanced scleral recovery and suppress myopia development in mice.

Timp2 修饰的明胶羟苯丙酸水凝胶可逆转小鼠的巩膜恢复增强并抑制近视发展

Tocilizumab Monotherapy or Combined With Methotrexate for Rheumatoid Arthritis: A Randomized Clinical Trial

托珠单抗单药治疗或联合甲氨蝶呤治疗类风湿性关节炎：一项随机临床试验

Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trial

Janus激酶1/2抑制剂KL130008治疗活动性类风湿性关节炎的疗效和安全性：一项随机、双盲、安慰剂对照的II期试验

Systemic lupus erythematosus related thrombotic microangiopathy: A retrospective study based on Chinese SLE Treatment and Research Group (CSTAR) registry

系统性红斑狼疮相关血栓性微血管病：基于中国系统性红斑狼疮治疗与研究组（CSTAR）注册登记的回顾性研究

Damage Evolution and Lifetime Prediction of Cement Asphalt Mortar Under High-Speed Train Frequency and Temperature Gradient Load

高速列车频率和温度梯度荷载作用下水泥沥青砂浆的损伤演化及寿命预测